Title |
How to treat VAP due to MDR pathogens in ICU patients
|
---|---|
Published in |
BMC Infectious Diseases, November 2014
|
DOI | 10.1186/1471-2334-14-135 |
Pubmed ID | |
Authors |
José Garnacho-Montero, Yael Corcia-Palomo, Rosario Amaya-Villar, Luis Martin-Villen |
Abstract |
The increasing occurrence of multidrug resistant (MDR) bacteria arises at a time when there is a lack of antibiotics active against these pathogens and few new antimicrobials are in the pipelines of the pharmaceutical industry. Treatment of ventilator-associated pneumonia (VAP) caused especially by MDR Gram-negative bacilli (GNB) represents a real challenge due to the dearth of treatment options. |
X Demographics
The data shown below were collected from the profiles of 6 X users who shared this research output. Click here to find out more about how the information was compiled.
Geographical breakdown
Country | Count | As % |
---|---|---|
Spain | 1 | 17% |
United Kingdom | 1 | 17% |
Unknown | 4 | 67% |
Demographic breakdown
Type | Count | As % |
---|---|---|
Members of the public | 6 | 100% |
Mendeley readers
The data shown below were compiled from readership statistics for 81 Mendeley readers of this research output. Click here to see the associated Mendeley record.
Geographical breakdown
Country | Count | As % |
---|---|---|
Unknown | 81 | 100% |
Demographic breakdown
Readers by professional status | Count | As % |
---|---|---|
Other | 11 | 14% |
Researcher | 10 | 12% |
Student > Postgraduate | 9 | 11% |
Lecturer | 8 | 10% |
Student > Ph. D. Student | 7 | 9% |
Other | 18 | 22% |
Unknown | 18 | 22% |
Readers by discipline | Count | As % |
---|---|---|
Medicine and Dentistry | 41 | 51% |
Nursing and Health Professions | 4 | 5% |
Biochemistry, Genetics and Molecular Biology | 3 | 4% |
Pharmacology, Toxicology and Pharmaceutical Science | 3 | 4% |
Agricultural and Biological Sciences | 2 | 2% |
Other | 5 | 6% |
Unknown | 23 | 28% |
Attention Score in Context
This research output has an Altmetric Attention Score of 11. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 10 May 2015.
All research outputs
#3,089,091
of 24,396,012 outputs
Outputs from BMC Infectious Diseases
#1,000
of 8,159 outputs
Outputs of similar age
#43,069
of 371,532 outputs
Outputs of similar age from BMC Infectious Diseases
#23
of 194 outputs
Altmetric has tracked 24,396,012 research outputs across all sources so far. Compared to these this one has done well and is in the 87th percentile: it's in the top 25% of all research outputs ever tracked by Altmetric.
So far Altmetric has tracked 8,159 research outputs from this source. They typically receive a lot more attention than average, with a mean Attention Score of 10.5. This one has done well, scoring higher than 87% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 371,532 tracked outputs that were published within six weeks on either side of this one in any source. This one has done well, scoring higher than 88% of its contemporaries.
We're also able to compare this research output to 194 others from the same source and published within six weeks on either side of this one. This one has done well, scoring higher than 88% of its contemporaries.